(wh)y-EHTG Plenary Session

Date: Thursday 17 October 2019
Time: 10:30 – 12:30
Chairs: Sanne Ten Broeke (The Netherlands), Mev Dominguez-Valentin (Norway)

Time Session
10:30 – 10:50 How to proceed with (wh)y-EHTG? – Aysel Ahadova (Germany), Sanne ten Broeke (The Netherlands)
10:50 – 11:00 Introduction mentoring program – Neil Ryan (UK)
11:00 – 11:15 Example of (wh)y-EHTG research initiative: Molecular analyses of tissue samples LS – Richard Gallon (UK) and Matthias Kloor (Germany)
11:15 – 11:30 Characterisation of clinical and pathological features associated with isolated PMS2 loss in Lynch Syndrome associated colorectal cancer – Aine Stakelum (Ireland)
11:30 – 11:45 Risk reduction depends on the level of Level of Compliance with Surveillance for Colorectal Cancer in Lynch Syndrome – Christina Therkildsen (Denmark)
11:45 – 12:00 Height and colorectal and endometrial cancer risk for persons with Lynch syndrome – J.G.M Brouwer (The Netherlands)
12:00 – 12:15 Unaffected germline genetic testing for individuals at high risk of Lynch Syndrome – results from first 3 years in practice – Demetra Georgiou (UK)
12:15 – 12:30 Delineating the cancer risks of MSH6 mutation carriers – preliminary results with simple statistics – Anne-Sophie van der Werf-‘t Lam (The Netherlands)
Top